A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)

NCT02684006 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

886

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Cell Cancer

Interventions

DRUG: Avelumab (MSB0010718C)
DRUG: Axitinib (AG-013736)
DRUG: Sunitinib

Sponsor

Pfizer